TargetMol

Setanaxib

Product Code:
 
TAR-T6099
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T6099-2mg2mg£98.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6099-5mg5mg£115.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6099-1mL1 mL * 10 mM (in DMSO)£119.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6099-10mg10mg£148.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6099-25mg25mg£220.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6099-50mg50mg£340.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6099-100mg100mg£499.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T6099-500mg500mg£994.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
GKT137831 is a potent, specific dual NADPH oxidase (NOX1/4) inhibitor.
CAS:
1218942-37-0
Formula:
C21H19ClN4O2
Molecular Weight:
394.86
Pathway:
Apoptosis; Immunology/Inflammation; Cell Cycle/Checkpoint; Metabolism
Purity:
0.9672
SMILES:
CN(C)c1cccc(c1)-c1n(C)c(=O)cc2[nH]n(-c3ccccc3Cl)c(=O)c12
Target:
NADPH-oxidase; Ferroptosis; NADPH

References

Aoyama T, et al. Hepatology. 2012, 56(6), 2316-2327. Zhao QD, et al. 2015, Doi:10.1161/CIRCULATIONAHA.114. 2011079. Gray SP, et al. Circulation. 2013, 127(18), 1888-1902. Green DE, et al. Am J Respir Cell Mol Biol. 2012, 47(5), 718-726.